Početna › Esencijalna trombocitemija › New York
Kliničke studije za Esencijalna trombocitemija u državi New York
7 studija za Esencijalna trombocitemija traži sudionike na lokacijama u državi New York.
Gradovi u državi New York
Službeni tekst studije (engleski)
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
- NYP/Weill Cornell Medical Center, New York
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT06661915A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College - Newyork-Presbyterian Hospita, New York
- i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07623200A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
- Icahn School of Medicine At Mount Sinai, New York
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT07008118Study of INCA036978 in Participants With Myeloproliferative Neoplasms
- Memorial Sloan Kettering Cancer Center, New York
- Mount Sinai School of Medicine, New York
- Weill Cornell Medicine, New York
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 22. srp 2026. · NCT07441694A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 17. tra 2026. · NCT06034002MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
- Memorial Sloan Kettering Cancer Center, New York
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 23. sij 2026. · NCT07362225MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
- Ruttenberg Treatment Center, New York
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 17. pro 2025. · NCT06541249Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.